BPC-157 (Body Protection Compound-157) is a synthetic 15-amino-acid research compound derived from a sequence found in human gastric juice, supplied for laboratory research only.
Key Research Areas
- Tissue repair models: Studied in preclinical tendon, ligament and muscle injury models, including angiogenesis (VEGF expression), collagen deposition and fibroblast migration (FAK-paxillin signalling).
- Gastrointestinal research: Examined in animal models of gastric and intestinal lesions, including NSAID-induced injury models.
- Inflammation and neuroscience: Studied for effects on inflammatory cytokines such as TNF-α and IL-6, and in nerve and brain injury models.
- Stability: Reported to be stable in gastric acid, which makes it a subject of interest in stability and delivery research.
Research Background
Published work on BPC-157 is predominantly preclinical (cell culture and animal models). Findings from these studies should not be extrapolated to humans. BPC-157 is a research compound and is not approved for therapeutic use in Australia.
Storage and Stability
Store the lyophilised powder at -20°C. Once reconstituted with bacteriostatic water, store at 2°C to 8°C and follow laboratory handling guidelines.
Quality
Supplied by Pure Glow Health with batch testing data and certificate of analysis (COA) information.
For laboratory and research purposes only. Not for human consumption, medical use, or veterinary use.
